Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal.

Original research | 2022
Stimulants, Withdrawal, Clinical guidance

We explored whether patients with benzodiazepine exposure at treatment entry would have similar 12-month retention compared to those without benzodiazepine exposure.

Original research | 2022
Substitution/OAT, Clinical guidance

The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.

Lit review | 2022
Withdrawal, Clinical guidance

This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.

Lit review | 2022
Withdrawal, Stimulants, Clinical guidance
Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance
Guide or handbook | 2022
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers
Guidelines | 2022
Clinical guidance, About prescribers, Policy/Regulatory, Safer supply

To understand what prescribing characteristics are associated with opioid overdose following buprenorphine taper.

Original research | 2022
Substitution/OAT, Overdose, Transitions in care/treatment, About PWUD, Clinical guidance
Handout | 2022
Clinical guidance, About pharmacists, About prescribers, Substitution/OAT, Transitions in care/treatment
Commentary | 2022
Withdrawal, About prescribers, Parents/caregivers, Clinical guidance
Guidelines | 2022
Withdrawal, Clinical guidance, Harm reduction, About prescribers
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Substitution/OAT, Carries/take-home doses
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Substitution/OAT, Carries/take-home doses, Illegal drugs
Guidelines | 2022
Clinical guidance, Policy/Regulatory, About prescribers, Harm reduction, Safer supply, Carries/take-home doses, Substitution/OAT
Guidelines | 2022
Clinical guidance, Carries/take-home doses, Policy/Regulatory
Guide or handbook | 2022
Drug checking, Digital health, Clinical guidance
Guidelines | 2019
Clinical guidance, About prescribers, Injecting drugs, Safer supply
Guide or handbook | 2020
Clinical guidance, Illegal drugs, About prescribers

Refine Your Search

Keywords
Format
Region